Nina Shah
Financials Analyst
Articles 755
Micron Technology Advances With Major Investment in Singapore Wafer Fabrication Facility
Company's $24 Billion Expansion Supports NAND Production Growth Amid Rising AI Demand
Shares of Micron Technology, Inc. (NASDAQ: MU) have surged following the company's announcement of a $24 billion investment to establish a new wafer f...
Rocket Lab Shares Gain Traction Following Significant Neutron Rocket Development
Investor Sentiment Improves as Company Advances Medium-Lift Reusable Rocket Project Despite Recent Testing Setback
Rocket Lab Corp witnessed a positive shift in its stock price as its latest milestone for the Neutron rocket construction outweighed earlier concerns ...
Centene Shares Plunge Following Medicare Advantage Payment Proposals
Minimal CMS Payment Increase and Stricter Risk-Adjustment Rules Pressure Centene’s Margins
Shares of Centene Corporation dropped significantly after the Centers for Medicare & Medicaid Services (CMS) announced a proposed net average payment ...
Clover Health: Buy the 2026 Profit Breakout Story at Deep Value Levels
Sequential premium revenue growth, improving operating cash flow and a clean balance sheet set up a path to profitability — entry at $2.35, stop $1.80, targets $3.50/$5.00.
Clover Health (CLOV) looks materially undervalued today. Revenue is growing sequentially, operating cash flow has flipped positive in recent quarters,...
D-Wave Quantum Advances Hybrid Quantum Defense Solutions and Expands Operations to Florida
Company enhances quantum-classical collaboration tools and plans headquarters relocation alongside academic partnerships
D-Wave Quantum Inc is advancing its quantum computing capabilities through new hybrid defense applications, platform upgrades, and a strategic expansi...
REGENXBIO Ahead of FDA Hunter Syndrome Decision - A High-Risk, Asymmetric Swing Trade
Approval decision in weeks makes RGNX a binary setup; pick your exposure and manage cash-burn risk
REGENXBIO (RGNX) faces a coming FDA decision on its gene therapy for Hunter syndrome. The stock is priced for outcomes; the company's balance sheet an...
Analysts Upgrade Baker Hughes Price Targets After Strong Q4 Performance
Robust Earnings and Revenue Drive Improved Market Sentiment for the Energy Services Provider
Baker Hughes Co. reported better-than-expected financial results for the fourth quarter, surpassing earnings and revenue estimates. Following the posi...
Starbucks Q1 Earnings Preview and Dividend Income Strategies
Evaluating expected earnings and how investors can leverage dividend payouts for steady monthly income
Starbucks Corporation is set to announce first-quarter earnings, with analysts anticipating a drop in earnings per share compared to last year. The co...
Analysts Launch Coverage on Visa and Other Major Stocks with Positive Outlooks
Several Wall Street analysts initiate ratings on prominent companies including Visa, Mastercard, and Intuitive Surgical, setting compelling price targets.
On Tuesday, key Wall Street analysts commenced coverage on several influential companies, assigning ratings and price targets that underscore their ou...
Anthropic CEO Dario Amodei’s Cautionary Perspective on AI’s Accelerating Risks and Societal Impact
An incisive examination of the imminent challenges posed by advanced artificial intelligence technologies
Dario Amodei, CEO of Anthropic, recently articulated an urgent warning about the rapid progression of artificial intelligence capabilities and the ext...